Introduction
The hepatitis B virus (HBV) is a hepatotrophic virus composed of a partially double-stranded circular DNA genome that causes acute and chronic hepatic injury. Persistent HBV infection is strongly associated with the development of hepatocellular carcinoma (Ganem and Varmus, 1987) . Four genes, S/preS, C/preC, P and X, are encoded by the viral genome (Tiollais et al., 1985) . The X gene encodes a 17 kDa protein, termed HBx, that has been shown to function as a transcriptional transactivator of a variety of viral and cellular promoter/enhancer elements (reviewed in Yen, 1996) .
HBx does not bind directly to DNA, but it is able to transactivate transcription through multiple cis-acting 7066 © Oxford University Press elements including AP-1, AP-2, ATF/CREB, NF-κB, C/EBP and Egr-1-binding sites (Maguire et al., 1991; Kekulé et al., 1993; Yoo et al., 1996) . However, the exact mechanism of transactivation still remains unresolved. It has been determined that HBx interacts in the nucleus with components of the basal transcription machinery, including RPB5, a subunit of all three mammalian RNA polymerases, and several transcription factors (Maguire et al., 1991; Cheong et al., 1995; Qadri et al., 1995; Haviv et al., 1996 Haviv et al., , 1998 Lin et al., 1997) . Thus, HBx may exert its effect by mimicking the cellular coactivator function (Haviv et al., 1996) . Another proposed mechanism for HBx activity involves the activation of signal transduction pathways such as the Ras/Raf/ERK and MEKK-1/JNK cascades, leading to induction of AP-1, NF-κB and probably other transcription factors (Benn and Schneider, 1994; Natoli et al., 1994b; Doria et al., 1995; Benn et al., 1996; Su and Schneider, 1996; Klein and Schneider, 1997) . Whether protein kinase C (PKC) is involved in the signal transduction pathways activated by HBx is less clear (Cross et al., 1993; Kekulé et al., 1993; Benn and Schneider, 1994; Murakami et al., 1994; Natoli et al., 1994a; Chirillo et al., 1996) . HBx has been found to be distributed in the cytoplasm, but also to some extent in the nucleus of transfected cells (Doria et al., 1995; Haviv et al., 1998) . Thus, HBx may have a dual function, one related to its cytoplasmic localization, that can mediate the activation of signal transduction pathways, and another nuclear, that may account for the interaction with transcription factors and components of the transcription apparatus to enhance the binding or activity of these proteins (Doria et al., 1995) .
Although there is emerging evidence of the involvement of HBx in hepatocarcinogenesis (Koike, 1995) , very little is known about the role that this viral protein plays in the intrahepatic inflammatory processes. In this context, we previously have reported the production of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) by hepatocytes from patients chronically infected by HBV. We also demonstrated that transient or stable transfection of the hepatoma cell line HepG2 with either the whole HBV genome or HBx expression vectors resulted in TNF-α production (González-Amaro et al., 1994) . In addition, it has been reported that the gene encoding human interleukin 8 (IL-8) is also transactivated by HBx (Mahé et al., 1991) . We have shown recently that HBxinduced TNF-α production by hepatocytes is regulated at the transcriptional level involving the activation of nuclear factor of activated T cells (NF-AT) (Lara-Pezzi et al., 1998) .
The expression of TNF-α, IL-8 and other cytokineencoding genes is regulated in a co-ordinate manner by the transcription factor NF-AT in cells of the immune system (Okamoto et al., 1994; Tsai et al., 1996; Rao et al., 1997) . Therefore, NF-AT is required for initiating and controlling effective immune and inflammatory responses. NF-AT is a family of transcription factors that includes at least four structurally related proteins; NF-AT1 (previously named NF-ATp), NF-ATc, NF-AT3 and NF-AT4. Multiple isoforms and species-specific variants of these proteins have also been identified. Although NF-AT proteins are not expressed exclusively by cells of the immune system (reviewed in Rao et al., 1997) , little information is available regarding the expression and function of NF-ATrelated proteins outside the immune system (Rao, 1994; Rao et al., 1997) .
The activity of NF-AT proteins is tightly regulated by the calcium/calmodulin-dependent phosphatase calcineurin (Sigal and Dumont, 1992; Jain et al., 1993; Crabtree and Clipstone, 1994; Cantrell, 1996; Loh et al., 1996) , a primary target for inhibition by the immunosuppressive drugs cyclosporin A (CsA) and FK506 (Schreiber and Crabtree, 1992; Shaw et al., 1995) . Calcineurin controls the translocation of NF-AT proteins from the cytoplasm to the nucleus of activated cells by interacting with an N-terminal regulatory domain conserved in all the members of the NF-AT family (Luo et al., 1996b) . NF-AT proteins are able to bind cooperatively with transcription factors of the AP-1 family to form composite NF-AT:AP-1 sites (Jain et al., 1993) , which are found in the regulatory elements of many genes that are transcribed inducibly by cells of the immune system (Boise et al., 1993; Cockeril et al., 1995; Jain et al., 1995; Rooney et al., 1995) .
In this report, we demonstrate that HBx transactivates transcription through NF-AT-binding sites in liver-derived Chang (CHL) cells, and that a chimeric Gal4-NF-AT protein, containing the N-terminal transactivation domain of NF-AT1 fused to the Gal4 DNA-binding domain (DBD) is activated by HBx. We also show that HBx induces, in CHL cells, NF-AT-containing protein complexes that bind independently of AP-1 to an NF-AT site of the murine IL-4 promoter. Furthermore, we demonstrate that HBx triggers dephosphorylation and nuclear translocation of NF-AT by a CsA-sensitive mechanism.
Results

Transactivation of NF-AT-dependent transcription by HBx
To analyze whether HBx was able to transactivate transcription through NF-AT-binding sites, CHL cells were transiently co-transfected with the HBx expression vector pSV-X along with a luciferase reporter plasmid driven by three tandem copies of the distal NF-AT site of the IL-2 enhancer (pNF-AT-Luc), which has been reported to bind NF-AT cooperatively with transcription factors of the AP-1 family (Boise et al., 1993; Northrop et al., 1993; Jain et al., 1995) . As shown in Figure 1A , the expression of HBx induced the NF-AT-dependent transcription 4-to 6-fold. Moreover, in the presence of either the mitogen phorbol 12-myristate 13-acetate (PMA) or the calcium ionophore A23187, HBx further induced (11-to 14-fold) NF-AT transcriptional activity, leading to luciferase expression levels similar to those obtained by co-stimulation with PMA plus the calcium ionophore, which provides a full stimulus for NF-AT-dependent transcription . In contrast, PMA or calcium ionophore alone 7067 exerted a weak effect on the induction of the transcriptional activity of the NF-AT enhancer, thus suggesting that HBx may compensate both the mitogenic signals induced by PMA and the calcium signals induced by calcium ionophore in the activation of NF-AT sites. Strikingly, HBx further increased the induction of the NF-AT enhancer by co-stimulation with PMA plus calcium ionophore ( Figure 1B) . A dominant-negative version of NF-AT, which lacks the DNA-binding domain and the C-terminal transactivation domain (Northrop et al., 1994) , was able to prevent the induction by HBx, either alone or in the presence of PMA and/or calcium ionophore ( Figure 1A and 1B). In addition, CsA, a pharmacological inhibitor of the phosphatase calcineurin that controls NF-AT activation, also blocked the induction by HBx as well as the synergistic induction by HBx and PMA plus calcium ionophore ( Figure 1C ), suggesting that activation of NF-AT proteins was mediating the induction of the NF-AT enhancer element by HBx.
The synergism of HBx and PMA plus the calcium ionophore was not due merely to an increase in HBx expression levels, since these agents did not induce significantly the activity of the promoter/enhancer elements driving the expression of HBx within the plasmid pSV-X (data not shown). Therefore, distinct mechanisms might be mediating the synergistic activation of the NF-ATdependent transcription by HBx. One such mechanism could be a further increase by HBx of the PMA-induced transcriptional activity of AP-1, which binds cooperatively with NF-AT to the NF-AT enhancer element. To address this issue, CHL cells were co-transfected with pSV-X vector and the reporter plasmid pAP-1-Luc, containing four AP-1-binding sites, and the transfected cells were either left untreated or stimulated with PMA or PMA plus calcium ionophore. As shown in Figure 1D , HBx further activated the AP-1-dependent transcription induced by PMA (not shown) and by PMA plus calcium ionophore. However, the activation of AP-1 transcriptional activity by HBx, either alone or in the presence of PMA or PMA plus calcium ionophore, was not blocked by CsA ( Figure 1D , and data not shown). Thus, the synergistic induction of the NF-AT enhancer element by HBx and PMA plus calcium ionophore may be due, at least in part, to a stronger activation of the AP-1 component of this composite NF-AT:AP-1 site.
To substantiate further that HBx was able to induce transcription through the NF-AT enhancer element via activation of NF-AT proteins, CHL cells were cotransfected with a cDNA encoding full-length NF-ATc along with the pNF-AT-Luc reporter plasmid, either in the presence or the absence of HBx. Although NF-ATc had a weak effect on the luciferase activity, probably due to its cytoplasmic localization after transfection, when co-transfected with HBx it potently enhanced NF-AT-Luc expression in a dose-dependent manner ( Figure  2A ). In addition, the HBx-mediated induction in the presence of NF-ATc was blocked by the dominantnegative mutant of NF-ATc (Figure 2A ). Similar functional results were obtained using clones of CHL cells stably transfected with HBx (CMX), in which NFATc enhanced HBx-mediated induction of the NF-AT element Ͼ6-fold ( Figure 2B ). 
HBx targets the transactivation domain of NF-AT
To confirm the role of NF-AT proteins in HBx-mediated transcriptional activation of the NF-AT enhancer element, a Gal4-derived reporter system was employed, which in mammalian cells responds only to artificial activators. To carry out these studies, the chimeric vector, pGal4-NF-AT1(1-415), encoding the Gal4 DBD fused to the transactivation domain of NF-AT1, or the parental vector pRSV-Gal4-DBD (Luo et al., 1996a) were co-transfected into CHL cells along with the luciferase reporter plasmid pGal4-Luc, either in the presence or the absence of the HBx expression vector pSV-X. As expected, HBx did not stimulate transcription when co-transfected with the control plasmid encoding the Gal4 DBD ( Figure 3A ). However, transcription of the pGal4-Luc reporter plasmid was induced up to 16-fold by HBx when co-transfected with Gal4-NF-AT1 expression vector ( Figure 3A ). Similarly, in CMX cells, HBx induced Gal4-Luc expressioñ 18-fold, when compared with control CMO cells, using three different amounts of Gal4-NF-AT1 expression vector ( Figure 3B ). Taken together, these results strongly indicate that HBx is able to activate NF-AT either by direct protein-protein interaction or by mimicking the signals involved in the activation of these proteins. 
HBx induces NF-AT DNA-binding activity
To examine whether HBx was able to induce the formation of NF-AT-containing DNA-protein complexes, electrophoretic mobility shift assays (EMSAs) were performed using a 32 P-labeled oligonucleotide that contained the NF-AT-binding site of the mouse IL-4 promoter, which can bind NF-AT independently of AP-1 (Rooney et al., 1994 (Rooney et al., , 1995 , and nuclear extracts from CHL cells stably transfected with either CMX or CMO. Three major specific complexes were resolved using nuclear extracts from HBx-expressing cells that were not detectable in CMO control cells ( Figure 4A ). These inducible complexes resulted from specific DNA binding since their formation was blocked by an excess of unlabeled IL4-NFAT oligonucleotide, but not by an unrelated oligonucleotide containing an SP-1-binding site. Three DNA-protein complexes, with electrophoretic mobility identical to those induced by HBx, were resolved using nuclear extracts from CMO cells treated with PMA plus calcium ionophore, which were used as a positive control for NF-AT activation ( Figure 4B ). It is noteworthy that PMA plus calcium ionophore treatment was a stronger stimulus than HBx for the formation of these complexes. In addition, HBx expression did not appear to enhance further the binding activity of these proteins induced by PMA plus calcium ionophore ( Figure 4B ). To characterize these HBx-induced complexes, an IL4-NFAT oligonucleotide bearing mutations in the core NF-AT-binding site was included in the competition assays. As shown in Figure 4C , two different amounts of the mutated IL4-NFAT oligonucleotide had no detectable effect on the generation of the inducible complexes, whereas similar amounts of the wildtype oligonucleotide completely abolished their formation. As an additional control, an oligonucleotide including an AP-1 consensus site failed to compete the specific bands generated with the NF-AT probe, suggesting that these complexes contained NF-AT-related proteins that bind to the oligonucleotide independently of the Fos/Jun family proteins.
To identify further the IL4-NFAT-binding factors induced by HBx, specific antibodies for NF-κB, NF-AT and Fos/Jun proteins were added to the binding reactions. As shown in Figure 4D , neither a pre-immune antiserum nor antisera against the NF-κB family members p50, Rel A and p52 (not shown) affected any of the DNAprotein complexes. In contrast, addition of a monoclonal antibody specific for NF-ATc prevented the formation of complex 1 and generated a supershifted band. An antiserum against NF-AT, which recognizes NF-AT1 and probably other members of the family (see Materials and methods), reduced complex 2 and prevented the formation of complex 3. On the other hand, an antiserum specific for NF-AT1 (672) significantly reduced complex 3, abolished the formation of complex 2 and generated a supershifted band. Taken together, these results suggest that complex 1 is composed mainly by NF-ATc, and that complexes 2 and 3 contain NF-AT1. These results also indicate that the inducible bands do not contain detectable amounts of NF-κB-related proteins, in agreement with previous observations which demonstrated that NF-κB family members bind with very low affinity to the NF-AT site of the mouse IL-4 promoter (Casolaro et al., 1995) . Consistent with the competition assays, the HBxinduced complexes were not affected by antibodies recognizing various members of the Fos and Jun families.
HBx triggers nuclear translocation and dephosphorylation of NF-AT
To investigate whether the activation of NF-AT-dependent transcription and NF-AT binding by HBx involved the nuclear translocation of NF-AT proteins, the cellular distribution of a transiently expressed HA-tagged NF-ATc protein (Northrop et al., 1994) was analyzed by indirect immunofluorescence staining in clones of CHL cells either expressing or not expressing HBx. As summarized in Table I ,~40% of the stable CMX cells displayed a nuclear Figure 4 ). In contrast, in control cells (CMO), either treated with dexamethasone or untreated, the fusion protein was found largely in the cytoplasm (Table I; Figure  5 ). A predominant nuclear localization of HA-NF-AT was observed in both HBx-expressing and non-expressing cells stimulated with PMA plus calcium ionophore (Table I ; Figure 5 ). Thus, the expression of HBx appears to induce constitutive nuclear translocation of NF-AT proteins in the absence of conventional calcium-mobilizing stimuli. Interestingly, the immunosuppressor CsA prevented the nuclear translocation of NF-AT triggered by both PMA plus calcium ionophore treatment and HBx expression (Table I ; Figure 5 ), indicating the involvement of the phosphatase calcineurin in the translocation of NF-AT induced by both stimuli. Similarly, transient co-transfection of CHL cells with the HA-NF-AT expression plasmid and the HBx expression vector pSV-X resulted in a predominant nuclear localization of HA-NF-AT, whereas the cells co-transfected with the control vector pSV-hygro displayed a cytoplasmic distribution of the fusion protein ( Figure 6 ). Moreover, treatment of the cells transfected with the control vector with PMA plus calcium ionophore also resulted in a nuclear staining pattern of HA-NF-AT. CsA blocked the nuclear translocation induced by HBx and by PMA plus calcium ionophore ( Figure 6 ). We further confirmed the effect of HBx on the translocation of NF-AT by transient co-transfection experiments in the T-cell line Jurkat, where the mechanism of NF-AT activation/translocation previously has been characterized (Luo et al., 1996b; Martínez-Martínez et al., 1997) . As shown in Figure 7 , co-expression of HBx and HA-NF-AT resulted in a clear nuclear localization of the fusion protein, whereas the control cells, transfected with the empty vector, displayed a cytoplasmic distribution of HA-NF-AT. A nuclear distribution of HA-NF-AT was also observed in both HBx-expressing cells and in control 7071 cells, when they were stimulated with PMA plus calcium ionophore. As above, CsA prevented the nuclear translocation triggered by HBx and a mitogenic stimulus (Figure 7) .
The activation and translocation of NF-AT proteins by various calcium-mobilizing stimuli involve the dephosphorylation of these proteins, and the dephosphorylated forms of NF-AT migrate more rapidly than fully phosphorylated forms on SDS-PAGE (Martínez-Martínez et al., 1997) . To examine whether HBx-mediated activation and translocation of NF-AT also resulted from its dephosphorylation, immunoblotting studies were performed in CMX and CMO cells transiently transfected with HA-tagged NF-ATc. The phosphorylation state of the fusion protein was analyzed by Western blot using an anti-HA antiserum (Figure 8) . In control cells (CMO), a single HA-NF-AT protein band was detected, which corresponded to the phosphorylated form, whereas in CMX cells a significant amount of HA-NF-AT was present in its rapidly migrating dephosphorylated form. Treatment with PMA plus calcium ionophore induced the dephosphorylation of a large amount of the transfected HA-NF-AT in both CMX and CMO cells. In agreement with the translocation studies, CsA prevented the dephosphorylation induced by HBx and PMA plus calcium ionophore.
Taken together, these results indicate that the activation of NF-AT by HBx is associated, at least in part, with its dephosphorylation and translocation, and that it is mediated by a mechanism involving deregulation of calcineurin.
Discussion
Chronic infection of the liver by HBV leads to profound changes in hepatocyte physiology including the expression of various molecules that normally are not expressed, or expressed at very low levels, by uninfected hepatocytes (Chisari and Ferrari, 1995) . It has been shown that the expression of many of these molecules is transcriptionally up-regulated by HBx, the transcriptional transactivator of HBV (Yen, 1996) . In this context, we have demonstrated that human hepatocytes infected by HBV produce the proinflammatory cytokine TNF-α both in vivo and in vitro (González-Amaro et al., 1994) . In addition, we have demonstrated that the proximal region of the TNF-α gene promoter contains target sequences for HBx transactivation (Lara-Pezzi et al., 1998) . The expression of TNF-α is almost exclusively restricted to cells of hematopoietic origin (Vassalli, 1992) , and is controlled by pre-existing transcription factors belonging to the NF-κB/Rel and NF-AT families, which ensure a rapid response to extracellular stimuli. In cells of the myeloid lineage, the inducible expression of TNF-α is regulated mainly by members of the NF-κB/Rel family (Trede et al., 1995; Yao et al., 1997) , whereas in lymphocytes the expression of TNF-α is tightly controlled by NF-AT proteins (Tsai et al., 1996) . We have shown that the HBx-mediated induction of the TNF-α gene promoter can be interfered with by a dominant-negative mutant of NF-AT, but not by the cytoplasmic inhibitor of NF-κB proteins IκBα (Lara-Pezzi et al., 1998) , suggesting that NF-AT proteins may have a role in the expression of TNF-α by HBV-infected hepatocytes.
We have demonstrated herein that HBx is able to activate NF-AT by a CsA-sensitive mechanism involving dephosphorylation and nuclear translocation of this trans- cription factor. Since the HBx-mediated transactivation experiments carried out in this study involved measuring reporter gene expression driven by a composite NF-AT:AP-1 site of the IL-2 enhancer, their interpretation was necessarily complex, and it might not be apparent whether NF-AT proteins or AP-1 proteins were affected. Given that both PMA and HBx can trigger the signal transduction pathways leading to activation of AP-1, it was expected that HBx would substitute effectively for PMA and synergize with calcium ionophore to stimulate the NF-AT enhancer element. In contrast, it had not been determined whether HBx was able to regulate the calcium-dependent pathways involved in the activation of the transcription factor NF-AT. In this regard, HBx appears to be able to substitute effectively for calcium ionophore and synergize with PMA to activate the pNF-AT-Luc reporter plasmid. Therefore, HBx appears to be sufficient to induce the intracellular signals necessary to activate transcription through composite NF-AT:AP-1 sites, present in many regulatory elements of cytokine-encoding genes, as demonstrated by the fact that HBx alone is able to transactivate the NF-AT enhancer element of the IL-2 gene.
In this work, we present three lines of evidence indicating that HBx is able to functionally activate NF-AT: first, the induction of the reporter plasmid pNF-AT-Luc by HBx, either alone or in synergy with PMA and/or calcium ionophore, can be disrupted by a dominant-negative mutant of NF-AT and by the immunosuppressive drug CsA; secondly, the transiently transfected NF-ATc protein potently activates the NF-AT enhancer element only in the presence of HBx; and thirdly, a chimeric Gal4-NF-AT protein, containing the transactivation domain of NF-AT, can mediate transcriptional activation by HBx. These functional data are supported further by the ability of HBx to trigger dephosphorylation, nuclear translocation and DNA-binding activity of NF-AT.
Mechanistically, dephosphorylation of NF-AT by the calcium/calmodulin-dependent phosphatase calcineurin appears to be the major activation pathway of NF-AT proteins in cells of the immune system . However, additional calcineurin-independent and CsAresistant pathways of NF-AT activation have also been reported (Ghosh et al., 1996) . In this regard, the HBxtriggered dephosphorylation and nuclear translocation of NF-AT as well as the HBx-induced transactivation of the NF-AT enhancer element are sensitive to CsA treatment, suggesting that the activation of NF-AT by HBx may be mediated, at least in part, by deregulation of calcineurin. However, a distinct mechanism that synergizes with the calcium/calcineurin pathway may also be involved in the activation of the NF-AT enhancer by HBx, as suggested by the fact that HBx is able to augment further the induction of the pNF-AT-Luc plasmid by co-stimulation with PMA plus calcium ionophore, which has been described to provide a full stimulus for NF-AT-dependent transcription in cells of the immune system . Although alternative explanations cannot be ruled out, our results indicate that the synergistic activation of the NF-AT enhancer by HBx and PMA plus calcium ionophore could be mediated, at least to some extent, through a stronger activation of the AP-1 component of this composite NF-AT:AP-1 site. It is also likely that HBx may activate the transcriptional activation domain of NF-AT, once this transcription factor has targeted its recognition sequences, by a mechanism involving direct protein-protein interaction, as has been shown for other transcription factors (Haviv et al., 1995 (Haviv et al., , 1996 Yoo et al., 1996) .
Recently, it has been shown that the tax gene product of the human T-cell leukemia virus (HTLV) induces IL-2 gene expression by a CsA-sensitive mechanism involving dephosphorylation and activation of NF-AT1 (Good et al., 1996 (Good et al., , 1997 . Moreover, it has been determined that activation of NF-ATc by the HIV transactivator Tat plays an important role on HIV gene expression and replication (Kinoshita et al., 1997) . In contrast to these lymphotrophic viruses, HBV infects mainly hepatocytes, in which no information is available regarding the expression and function of NF-AT-related proteins. For the first time, to our knowledge, we provide herein evidence of expression of NF-AT family members within CHL cells, and that these NF-AT proteins can be activated by HBx, as demonstrated by reporter gene and mobility shift assays. Our findings raise further questions about the expression of other NF-AT-regulated genes by HBV-infected hepatocytes. In this context, it has been determined that HBx transactivates the human IL-8 gene through a κB-like cisacting element (Mahé et al., 1991) , which recently has been shown to behave in vivo as a functional NF-AT site in T cells (Okamoto et al., 1994; Rao et al., 1997) . The expression of other pro-inflammatory cytokines such as IL-1β, interferon-γ and IL-6 has been described to take place in the liver during acute and chronic hepatitis B, but it has not been established yet whether these cytokines are produced only by non-parenchymal cells or also by hepatocytes (Fukuda et al., 1995; Shindo et al., 1996) . On the other hand, it is well known that HBV, although unable to replicate actively, can also infect cells of the immune system (Ferrari et al., 1992; Franco et al., 1992) , making it conceivable that HBx, like Tax and Tat, may also induce the expression of cytokine-encoding genes in these cells.
The liver may function as an important source of cytokine production and participates in the systemic defence mechanisms that take place after injury or infection (Andus et al., 1991) . It is likely that the infection of hepatocytes by HBV may initiate the cytokine cascade that mediates the host immune response and inflammatory process by inducing locally the expression of several cytokines that are up-regulated by NF-AT and other HBxinducible transcription factors. The underlying abnormality in chronic hepatitis B is an alteration of the cell-mediated immune response, which remains strong enough to cause hepatocellular necrosis but insufficient to clear the virus (Chisari and Ferrari, 1995) . It recently has been reported that prolonged exposure of T lymphocytes to TNF-α, a cytokine that is highly produced in HBV-infected patients, suppresses T-cell function by attenuating T-cell receptor signaling (Cope et al., 1997) , suggesting that this might be a mechanism of viral persistence. Chronic liver injury and the inflammatory and regenerative responses create the stimuli for DNA damage that may lead to the development of hepatocellular carcinoma. Elucidation of the molecular basis for the HBV-triggered cytokine network may yield therapeutic strategies to terminate chronic HBV infection and reduce the risk of its sequellae.
Materials and methods
Plasmid constructs
The expression vectors pSV-X and pSV-hygro, harboring the HBx open reading frame (ORF) and the bacterial hygromycin phosphotransferase gene, respectively, under the control of the SV40 early promoter/enhancer have been described elsewhere (Chirillo et al., 1996) . The expression vectors pMMTV-X and pMMTV-CAT, containing the HBx ORF and the bacterial chloramphenicol acetyltransferase (CAT) gene under the control of the glucocorticoid-inducible promoter/enhancer of the mouse mammary tumor virus (MMTV), were a gift of Dr M.Levrero (Rome, Italy) (Chirillo et al., 1997) . The plasmids pNFATcwt and pSH102CΔ418 (a kind gift of Dr G.Crabtree, Stanford, CA) are derivatives of pBJ5 vector and encode, respectively, the full-length protein NF-ATc cDNA and an NF-ATc deletion mutant (1-418), fused to an N-terminal HA tag, which functions as a dominant-negative mutant for all the NF-AT isoforms. pSH102CΔ418 lacks the DNA-binding domain and the C-terminal transactivation domain, but maintains its ability to interact with calcineurin through the NF-AT homology region (Northrop et al., 1994) . The reporter construct pNFAT-Luc contains three tandem copies of the distal NF-AT-binding site of the human IL-2 enhancer fused to the minimal IL-2 promoter and was provided by Dr G.Crabtree (Durand et al., 1988) . The plasmid pAP1-Luc that contains the minimal rat prolactin promoter and four copies of the human collagenase TRE site (Lara-Pezzi et al., 1998) was a gift of Dr R.A.Flavell (Howard Hughes Medical Institute, Yale University, New Haven, CT). The pGal4-Luc reporter plasmid, which carries five copies of the Gal4-binding sequence fused to the luciferase gene (kindly provided by Dr R.Perona), has been described previously (Minden et al., 1995) . The plasmids pGal4-NFAT1(1-415) encoding the transactivation domain of NF-AT1 (amino acids 1-415) in-frame with the Gal4 DBD, and pRSV-Gal4-DBD, which includes only the DBD (amino acids 1-147), were a gift of Dr A.Rao (Boston, MA) (Luo et al., 1996a) .
Cell culture and reagents CHL cells (ATCC CCL13) were grown at 37°C with a 5% CO 2 atmosphere in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine and 50 μg/ml gentamycin. CMO and CMX clones were generated by stably transfecting CHL cells with the plasmids pMMTV-CAT and pMMTV-X, respectively, which drive the expression of CAT or HBx in a glucocorticoid-inducible manner (Chirillo et al., 1997) . Clones were selected in the presence of 0.2 mg/ml hygromycin (Boehringer Mannheim, Mannheim, Germany), and the inducible expression of HBx was analyzed by PCR and Northern blot. In order to confirm the results obtained with these transfectants, different clones of CMO and CMX cells were used in each experiment. The T-cell line Jurkat was grown in RPMI 1641 (Life Technologies LTI, Paisley, Scotland), supplemented with 10% FCS, 2 mM L-glutamine and 50 μg/ml gentamycin. Where indicated, CMO and CMX cells were treated with 1 μM of the water analog of dexamethasone D-2915 (Sigma, St Louis, MO). PMA and the calcium ionophore A23187 were obtained from Sigma. CsA was purchased from Sandoz Pharmaceuticals Co. (East Hanover, NJ).
Transfections and luciferase assays CHL cells, at 50-70% confluence, were co-transfected with 0.2 μg of the reporter plasmids pNFAT-Luc or pAP-1-Luc, along with 5 μg of pSV-X, or the negative control pSV-hygro, using the DOSPER reagent (Boehringer Mannheim), according to the manufacturer's instructions. Where indicated, 2 μg of the dominant-negative NF-AT expression vector pSH102CΔ418 or varying amounts of the full-length NF-ATc expression vector pNF-ATcwt were added. The empty vector pBJ5 was used to keep the total amount of DNA constant. The transfected cells were either left untreated or stimulated with PMA (10 ng/ml) and/or calcium ionophore (1 μM) for 16 h prior to harvesting. Where indicated, cells were treated with CsA (200 ng/ml) for 40 h. CMO and CMX cells were co-transfected with 0.2 μg of pNF-AT-Luc, 0.2 μg of pNF-ATcwt or pBJ5 and 5 μg of the carrier plasmid pGEM-7 (Promega, Madison, WI). Where indicated, 2 μg of pSH102CΔ418 were included. For Gal4-dependent transactivation experiments, 1 μg of the pGal4-Luc reporter construct, 5 μg of pRSV-Gal4-DBD or pGal4-NFAT1(1-415) and increasing amounts of pSV-X were transfected into CHL cells using the DOSPER reagent. CMO and CMX cells were transfected with 1 μg of reporter plasmid pGal4-Luc and increasing amounts of the pGal4-NF-AT1(1-415) vector. In order to induce the expression of HBx, 1 μM dexamethasone was added to transfected CMO and CMX cells 16 h prior to harvest. The results obtained with the stable transfectants were confirmed using different clones of CMO and CMX cells. Luciferase activity was measured in a Lumat LB9501 luminometer (Berthold, Wildbad, Germany), and normalized to transfection efficiency, which was determined by co-transfecting 0.5 μg of pRL-null and measuring Renilla luciferase activity using the Dual-Luciferase Reporter Assay System (Promega).
Electrophoretic mobility band shift assays
Small-scale nuclear extracts were prepared from CMO and CMX cells at 30-70% confluence either untreated or stimulated with PMA (10 ng/ml) plus calcium ionophore (1 μM) as previously described (Schreiber et al., 1989) . Binding reactions were performed at 4°C in a volume of 18.5 μl containing 10 mM HEPES pH 7.6, 10% glycerol, 50 mM KCl, 6 mM MgCl 2 , 0.1 mM EDTA, 1 mM dithiothreitol, 2.5 μg of poly(dI-dC), 0.75-1 ng of 3Ј-end-labeled probe and 2 μg of nuclear extracts. For competition, a 40-or 130-fold excess of unlabeled oligonucleotide was added to the reaction prior to the addition of the probe. The DNA-protein complexes were resolved by electrophoresis on 4% polyacrylamide gels. The nucleotide sequences of the oligonucleotides (and their complementaries) used are: 5Ј-gatcATAAAATTTT-CCAATGTAAA-3Ј (NF-AT-binding site of the murine IL-4 promoter), 5Ј-gatcATAAAATTTaggtATGTAAA-3Ј (mutated NF-AT-binding site of the murine IL-4 promoter), 5Ј-gatcATTCGATCGGGGCGGGGCGAG-3Ј (SP-1 consensus binding site) and 5Ј-gatcCGCTTGATGAGTCA-GCCGGAA-3Ј (AP-1-binding site).
For supershift assays, 0.5 μl of antibody was added 10 min prior to the labeled probe, using the following antibodies: anti-NFAT1 antiserum (Upstate Biotechnology, Lake Placid, NY), which recognizes NF-AT1 but its cross-reactivity with other NF-AT family members has not been tested; anti-NFAT1 antiserum 672, which was raised against the synthetic peptide NH 2 -CSPPSGPAYPDDVLDYGLK (residues 53-70 of human NF-AT1) as previously described (Lyakh et al., 1997) ; anti-NFATc monoclonal antibody (Alexis Corporation, San Diego, CA); anti-Jun and anti-Fos family antisera (Santa Cruz Biotechnology, Santa Cruz, CA); and anti-RelA and anti-p50 antisera (provided by Dr E.Muñoz, Córdoba, Spain) (Kieran et al., 1990) .
Immunofluorescence analysis CMO and CMX cells were transfected with 1.5 μg of pSH102CΔ418, which expresses an HA-tagged NF-ATc mutant, and 8.5 μg of an irrelevant plasmid using the DOSPER reagent. At 24 h after transfection, cells were plated on coverslips and were grown overnight in the presence or absence of 1 μM dexamethasone. Where indicated, cells were treated for 2 h with CsA (200 ng/ml) and/or PMA (10 ng/ml) plus calcium ionophore (1 μM) for 30 min. The subcellular localization of NF-AT was analyzed by immunofluorescence with an anti-HA antibody (12CA5). The percentages of cells displaying total or partial nuclear translocation of HA-NF-AT were visually scored after counting at least 50 HAexpressing cells. The statistical analysis was performed using different clones of CMO and CMX cells.
CHL cells were co-transfected with 0.5 μg of pSH102CΔ418 and 1.5 μg of either pSV-X or the control plasmid pSV-hygro, using the FuGENE-6 liposomal reagent, following the manufacturer's instructions. Where indicated, cells were treated with CsA (200 ng/ml) for 2 h and/ or with PMA (10 ng/ml) plus calcium ionophore (1 μM) for 30 min. The subcellular localizaton of HA-NF-AT was analyzed by immunofluorescence with the anti-HA antibody 12CA5.
Jurkat cells (10 7 ) were transiently co-transfected with 1.5 μg of pSH102CΔ418 and 3.5 μg of pSV-X, or the control plasmid pSV-hygro, using the Lipofectin reagent (Life Technologies), according to the manufacturer's recommendations. At 48 h after transfection, cells were plated on polylysine-coated coverslips and were either left untreated or treated with CsA (200 ng/ml) for 2 h and/or PMA (10 ng/ml) plus calcium ionophore (1 μM) for 30 min. HA-NF-AT localization was analyzed by immunofluorescence with the anti-HA antibody 12CA5.
Western blots
CMO and CMX cells were transfected with 1.5 μg of pSH102CΔ418 and 8.5 μg of an irrelevant plasmid, and 24 h later were stimulated overnight with 1 μM dexamethasone and, where indicated, cells were treated for 2 h with CsA (200ng/ml) and/or PMA (10 ng/ml) plus calcium ionophore (1 μM) for 30 min. After washing twice with icecold phosphate-buffered saline (PBS), cells were lysed on the plate with 100 μl of Laemmli buffer, boiled for 5 min and separated by electrophoresis in SDS-8% polyacrylamide gels under reducing conditions. Proteins were transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA) that were incubated in blocking solution [5% skimmed milk in Tris-buffered saline (TBS) buffer] overnight at 4°C, washed three times in TBS-T (0.1% Tween-20 in TBS) and incubated with the anti-HA antibody (12CA5) supernatant (diluted 1:5 in TBS-T) for 2 h at room temperature. Membranes were washed three times in TBS-T and incubated with a peroxidase-labeled rabbit anti-mouse IgG (DAKO, Glostrup, Denmark), 1:3000 in TBS-T, for 2 h at room temperature. After three washes in TBS-T and one wash in H 2 O, membrane-bound antibody was visualized with the enhanced chemiluminescence (ECL) detection reagent (Amersham, Little Chalfont, UK).
